Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC HyperScribe™ All in One mRNA Synthesis Kit Plus 1 (ARCA, 5mCTP, UTP, T7, poly(A)), 25rxns
SDP

Supplier:  Apexbio Technology LLC K106425

Encompass_Preferred

HyperScribe™ All in One mRNA Synthesis Kit Plus 1 (ARCA, 5mCTP, UTP, T7, poly(A)) is designed for quick production of ARCA capped, 5mCTP and UTP modified, poly(A) tailed mRNA in vitro. Capped mRNA is synthesized by co-transcriptional incorporation of Anti-Reverse Cap Analog (ARCA, Catalog No. B8175) using T7 RNA Polymerase. The capping of ARCA ensures high translation efficacy. The addition of 5mCTP (Catalog No. B7967) / UTP (Catalog No. B7972) can reduce host cell immune response. After a brief DNase I treatment to remove the template DNA, capped and modified mRNA is poly(A) tailed with Poly(A) Polymerase. Polyadenylation (i.e. addition of Poly(A) tail) plays an important role in the stabilization of RNA in eukaryotes and enhances the efficiency of translation initiation. The kit contains sufficient reagents to carry out 25 reactions, 20 l each time. Up to 25-180 g of RNA can be generated with 1 g of control template per standard reaction.

Catalog No. 50-199-8233


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.